Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Atorvastatin Calcium NDC 55700-877 by Quality Care Products, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - CamScanner 08 05 2020 15.31.07 1

image description - CamScanner 08 05 2020 15.31.07 1

The text provides information about a medication called ATORVASTATIN CALCIUM 10 MG, packaged by ZM% &/ZE PRODUCTE and distributed in the US. The medication comes in a white, oval-shaped tablet, and each package contains 30 tablets. The GTIN and NDC numbers are also listed, and there is a warning to keep the medication out of children's reach. The medication is produced by Accord Healthcare in Durham, NC, and manufactured by Intas Pharmaceuticals in Ahmedabad, India. The text recommends consulting with a physician and reviewing the manufacturer's insert.*

image description - CamScanner 08 06 2020 09.30.33 1

image description - CamScanner 08 06 2020 09.30.33 1

This is a description of a medication package containing Atorvastatin Calcium 20mg tablets manufactured by Intas Pharmaceuticals Limited in India and distributed by Packaged Specialty Cane Products in Ohio. The medication comes in a bottle with 30 tablets, marked with a lot number and expiration date. The tablets are white, oval-shaped, and available only by prescription.*

Figure - atorvastatin calcium figure 1

Figure - atorvastatin calcium figure 1

Figure - atorvastatin calcium figure 2

Figure - atorvastatin calcium figure 2

This appears to be a graph showing the cumulative hazard percentage over time for a placebo group and a group taking Atorvastatin, a medication typically used to lower cholesterol. The graph indicates that there was a lower incidence of primary endpoint events (not specified in the available text) in the group taking Atorvastatin compared to the placebo group. The hazard ratio and p-value are also shown. The data represents a four-year follow-up period.*

Figure - atorvastatin calcium figure 3

Figure - atorvastatin calcium figure 3

This is a table presenting the percentage of subjects experiencing an event after taking Atorvastatin at two different doses: 10mg and 80mg. The results show that the group taking Atorvastatin 80mg had a lower risk of experiencing a major cardiovascular endpoint compared to the 10mg group. The results are statistically significant (HR=0.78, p=0.0002). The table also shows that the time to the first major cardiovascular endpoint was monitored over 5 years.*

Chemical Structure - atorvastatin calcium structure

Chemical Structure - atorvastatin calcium structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.